Extract The recent European Respiratory Society (ERS)/European Alliance of Associations for Rheumatology (EULAR) clinical practice guidelines for connective tissue disease-associated interstitial lung disease (CTD-ILD) represent a commendable collaborative effort and an important step toward harmonising clinical practice and improving outcomes for patients with these complex disorders 1, 2. We commend the authors for addressing key aspects of disease assessment and treatment.
Uzunhan et al. (2026) studied this question.